作者: Walid Zaher , Adiba Isa , Moustapha Kassem
DOI: 10.1007/978-3-319-13266-2_4
关键词:
摘要: There is an increasing interest in using stem cells treatment of degenerative diseases such as Parkinson’s disease, liver failure, leukemia, diabetes, osteoarthritis (OA), and osteoporosis, for which there no curative therapy. In this context, skeletal tissue regeneration being addressed a number common clinical conditions including repair non-healing fractures bone defects through transplantation (also known stromal or adult mesenchymal cells, MSCs) either alone with osteoinductive/osteoconductive scaffolds. the present Chapter, we will biological characteristics MSCs give update regarding their use preclinical animal models trials.